Skip to content

SANA - Sana Biotechnology, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Sana Biotechnology Inc

SANA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SANASana Biotechnology Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $6.55
52-wk low: $2.61
Prev close: $4.40
Mkt cap: $1.23B
Beta: 2.10
P/B: 7.0x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$284.9M

MW
Marshall Wace
Q2 2026 13F
$10.2M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 13.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.2B

Valuation

P/B7.03

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SANA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.23B
Beta: 2.10

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-152.9%

$4.3M

position

AQ

AQR

Q2 2026 13F

$3.4M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for SANA

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.13+13.3%

-$0.15 expected

Next report

What the street expects next

EPS expected

-$0.10

-$0.10 to -$0.10

Revenue expected

$0.00

6 analysts

Estimate drift

+0.02

Change in 30 days

-152.9%

ROA-29.2%

Growth

Beta2.10